(0.07%) 5 473.27 points
(0.10%) 39 151 points
(0.37%) 17 783 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.70
(0.20%) $28.93
(3.50%) $1 020.90
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases...
Stats | |
---|---|
今日成交量 | 755 858 |
平均成交量 | 99 535 |
市值 | 5.16M |
EPS | $-0.460 ( Q4 | 2023-02-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0286 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00200 (3.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-02-24 | Appelhans Dannielle | Sell | 10 385 | Common Stock |
2023-02-01 | Cagnoni Pablo J | Sell | 8 448 | Common Stock |
2023-01-31 | Appelhans Dannielle | Sell | 7 500 | Restricted Stock Units |
2023-01-31 | Appelhans Dannielle | Buy | 7 500 | Common Stock |
2023-02-01 | Appelhans Dannielle | Sell | 3 878 | Common Stock |
INSIDER POWER |
---|
-14.61 |
Last 96 transactions |
Buy: 4 525 378 | Sell: 349 777 |
音量 相关性
Rubius Therapeutics Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Rubius Therapeutics Inc 相关性 - 货币/商品
Rubius Therapeutics Inc 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-2.56 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-2.56 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-2.23 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-2.08 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Rubius Therapeutics Inc
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。